Despite Concerns Over Extrapolation, Bevacizumab Biosimilars Are Widely Used in mCRC
May 5th 2023A review article investigating the use of bevacizumab biosimilars found that despite lingering concerns about their usage for extrapolated indications, bevacizumab biosimilars are regularly used in metastatic colorectal cancer (mCRC) even though clinical tests only evaluate them in patients with lung cancer.
Read More
Integrating Molecular Profiling of Adrenocortical Carcinoma Into Clinical Practice
December 2nd 2021Processes used to identify and understand genetic markers detailing the prognosis and responsiveness to therapy in adrenocortical carcinoma (ACC) face a number of implementation barriers, limiting the potential for individualized ACC management.
Read More
Researchers Report Promising Strategy to Develop Personalized Therapy for Neuroblastoma
November 18th 2021Using cell cultures from pediatric patients with neuroblastoma, researchers performed drug-response testing and investigated correlations between copy number and cytotoxicity of drug treatment.
Read More